NCT03899480View on ClinicalTrials.gov

Adoptive Transfer of Haploidentical NK Cells and N-803

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
HivHIV InfectionsImmune Deficiency
Interventions
BIOLOGICAL

Haploidentical Natural Killer (NK) Cells

infusion with N-803 activated NK cells

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03899480 - Adoptive Transfer of Haploidentical NK Cells and N-803 | Biotech Hunter | Biotech Hunter